In the CNS, OPN was originally found to be upregulated in lesions of patients suffering from multiple sclerosis (MS), a devastating autoimmune disease causing neurological deficits that may ultimately culminate in invalidity or death [14]. The gene discussed is SPP1; the disease is myeloid sarcoma.